Skip to main content
RNXT
NASDAQ Life Sciences

Peer-Reviewed Case Study Shows 52% Tumor Activity Reduction with RenovoRx's TAMP™ in Pancreatic Cancer

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.885
Mkt Cap
$38.326M
52W Low
$0.701
52W High
$1.45
52W Position info
26% above low
Off High info
39% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

RNXT sits 26% above its 52-week low of $0.701.

Summary

RenovoRx highlighted a peer-reviewed case study published in *Radiology Case Reports* supporting its TAMP™ system and RenovoCath for intra-arterial gemcitabine delivery in locally advanced pancreatic cancer. The study detailed a patient who experienced a 52% reduction in tumor metabolic activity after treatment. This publication adds to the growing body of evidence for RenovoRx's targeted therapy platform, following recent positive updates on its Phase III TIGeR-PaC clinical trial progress and promising pharmacokinetic data from a sub-study in May. For a small biotech, this external, peer-reviewed validation is important for demonstrating the efficacy and procedural flexibility of its core technology.

At the time of this announcement, RNXT was trading at $0.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $38.3M. The 52-week trading range was $0.70 to $1.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

RNXT - Latest Insights

RNXT
Nov 05, 2026, 4:18 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $1.14 info
Change: -$0.0426 (-4%) info
Market Cap: $53.704M info
RNXT
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $1.14 info
Change: -$0.0469 (-4%) info
Market Cap: $53.704M info
RNXT
Aug 25, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $1.14 info
Change: -$0.2069 (-15%) info
Market Cap: $53.704M info
RNXT
Aug 13, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.25
Real-time Price: $1.14 info
Change: -$0.1072 (-9%) info
Market Cap: $53.704M info
RNXT
Aug 12, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.19
Real-time Price: $1.14 info
Change: -$0.0455 (-4%) info
Market Cap: $53.704M info